InvestorsHub Logo
Followers 40
Posts 1751
Boards Moderated 0
Alias Born 05/11/2009

Re: None

Tuesday, 01/27/2015 8:50:18 AM

Tuesday, January 27, 2015 8:50:18 AM

Post# of 146211
"Hemispherx Biopharma (HEB) announced that in a new publication in the journal mBio, scientists at the U.S. Army Medical Research Institute of Infectious Disease, Harvard University, and Massachusetts Institute of Technology studied genetic changes in the Ebola virus circulating in West Africa and concluded that genomic drift of the EBOV over time may be sufficient to block the action of otherwise potential therapies that target EBOV genetic sequences."

from our friends on yahoo message boards
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News